Instead, they are considering whether that patient's illness is, in fact, under control with Humira. If it's not, they are switching to drugs that use other mechanisms. This benefits Skyrizi and ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...

Otezla (apremilast) is Celgene's attempt to break into the immunology field currently dominated by the TNF blocker drugs, led by AbbVie's Humira. The oral treatment has a novel mechanism ...